Side Effects

Fertility Preservation

To help doctors give their patients the best possible care, the American Society of Clinical Oncology (ASCO) asks its medical experts to develop recommendations for specific areas of cancer care. In 2006, ASCO developed recommendations for fertility preservation for people with cancer. These recommendations were updated in 2013 to reflect new research and highlight the importance of fertility preservation discussions. This guide for patients is based on ASCO's recommendations.

Key Messages:

Preventing and Treating Blood Clots

To help doctors give their patients the best possible care, the American Society of Clinical Oncology (ASCO) asks its medical experts to develop recommendations for specific areas of cancer care. In 2007, ASCO developed a clinical practice guideline about preventing and treating blood clots for people with cancer. These recommendations were updated in 2013 to reflect new research. This guide for patients is based on ASCO's recommendations.

Key Messages:

Bone-Modifying Drugs for Breast Cancer

To help doctors give their patients the best possible care, the American Society of Clinical Oncology (ASCO) developed evidence-based recommendations for using drugs, called bone-modifying drugs, for advanced breast cancer that has spread to the bone to help prevent bone-related problems. In 2011, this guideline was updated based on results from clinical trials of these drugs, including new information about a possible condition experienced by some people taking bone-modifying drugs. It also includes a new drug, denosumab (Xgeva), which was approved by the U.S.

White Blood Cell Growth Factors

January 25, 2008: Special Announcement on sargramostim (Leukine): Patients and doctors need to be aware that there has been a voluntary market suspension of the current liquid formulation of this drug because of an upward trend in spontaneous reports of adverse reactions, including syncope (fainting). The lyophilized (freeze-dried) form of the drug is not affected. See the U.S. Food and Drug Administration (FDA) web site at www.fda.gov for more information.

Introduction

Subscribe to RSS - Side Effects